Related Experiment Video
Updated: Jul 13, 2026
08:44
Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
Published on: October 17, 2025
Tuberous sclerosis complex: advances in diagnosis, genetics, and management
Robert A Schwartz1, Geover Fernández, Katarzyna Kotulska
1Department of Dermatology, New Jersey Medical School, Newark, NJ 07103, USA. roschwar@cal.berkeley.edu
Journal of the American Academy of Dermatology
|July 20, 2007
Summary
Tuberous sclerosis complex (TSC) is a genetic disorder causing tumors. Advances in diagnosing TSC, understanding its genetics, and new treatments like rapamycin offer hope for patients.
Area of Science:
- Genetics
- Dermatology
- Neurology
Background:
- Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome.
- It involves hamartomas in multiple organs, including skin, brain, heart, kidneys, liver, and lungs.
- While the classic triad includes seizures, mental retardation, and angiofibromas, its presentation varies widely.
Purpose of the Study:
- To review recent advances in TSC diagnosis and genetics.
- To discuss the utility of revised 1998 clinical criteria for TSC.
- To explore current and emerging TSC treatment options.
Main Methods:
- Literature review of recent significant advances in TSC.
- Analysis of diagnostic criteria and genetic underpinnings.
- Discussion of therapeutic interventions, including rapamycin (sirolimus).
Main Results:
- Two tumor suppressor genes, TSC1 and TSC2, are identified.
- Clinical presentation and diagnostic criteria have been refined.
- Therapeutic trials with rapamycin show promise for TSC management.
Conclusions:
- Understanding TSC genetics and refining diagnostic criteria improve patient care.
- Emerging treatments like rapamycin offer new therapeutic avenues for TSC.
- Continued research is vital for managing this complex multisystem disorder.
Related Concept Videos
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...